International Journal of Pharmacy Practice最新文献

{"title":"Mental health support in community pharmacy: inclusion of the lived experience voice in supporting service provision.","authors":"Victoria Stewart, Sara S McMillan, Helena Roennfeldt, Jie Hu, Jack C Collins, Sarira El-Den, Claire O'Reilly, Amanda J Wheeler","doi":"10.1093/ijpp/riaf046","DOIUrl":"https://doi.org/10.1093/ijpp/riaf046","url":null,"abstract":"<p><strong>Objectives: </strong>Community pharmacists, as primary healthcare practitioners, play a crucial role in supporting mental health consumers. They often serve as the first point of contact and see mental health consumers more frequently than other healthcare professionals. While their contributions to mental healthcare are increasingly recognized, insight is emerging about the factors that support pharmacists in providing mental healthcare. The aim of this study was to assess the applicability of a framework for pharmacists, pharmacy staff and consumers' empowerment in mental health.</p><p><strong>Methods: </strong>This study used interview data from pharmacists and mental health consumers who had participated in the Australian PharMIbridge RCT. PharMIbridge pharmacists delivered a person-centred, goal-oriented medication support service to mental health consumers. The qualitative data investigating the experiences of pharmacists (n = 16) and consumers (n = 26) were categorized in relation to the existing framework and inconsistencies or differences discussed to identify new factors.</p><p><strong>Key findings: </strong>Study results supported many aspects of the published framework, with two new factors (prevalence of mental distress and looking beyond the mental illness) suggested for inclusion. Additionally, eight factors were expanded with further nuanced details and experiences from the data and are presented with supporting quotations.</p><p><strong>Conclusions: </strong>This study adds further understanding of the factors that moderate the empowerment of pharmacists and consumers in mental healthcare within community pharmacy settings. The inclusion of consumer perspectives has enriched the framework, which can be further utilized by policymakers and community pharmacists to support targeted primary healthcare responses with mental health consumers.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient prioritization for pharmaceutical intervention in the hospital setting: a retrospective cross-sectional study.","authors":"Maude Plourde, Chantal Gilbert, Mélanie Noël, Sophie Ruelland, Pierre-Hugues Carmichael, Danielle Laurin","doi":"10.1093/ijpp/riaf033","DOIUrl":"https://doi.org/10.1093/ijpp/riaf033","url":null,"abstract":"<p><strong>Objectives: </strong>Prioritization of patients requiring pharmaceutical intervention is critical given limited resources. Data from pharmacy software could be used to target patients. This retrospective cross-sectional study aimed to describe the method implemented in a hospital care unit to prioritize hospitalized patients and compare the characteristics of those receiving a pharmaceutical intervention and those not. This study also explored the possibility of predicting an intervention using pharmacy software data.</p><p><strong>Methods: </strong>All patients admitted to a hospital care unit between November 2019 and April 2020 were included. Prioritization with the pharmacy software was based on preselected admission diagnoses and by operating an antimicrobial stewardship programme. Medications and patients' characteristics were extracted from the pharmacy software. Pharmaceutical interventions and drug-related problems were collected from medical records. Two machine learning algorithms were used to produce rule-based models for pharmaceutical intervention prediction.</p><p><strong>Key findings: </strong>A total of 850 admissions were included. A medication review following prioritization with the pharmacy software or due to external requests was carried out by clinical pharmacists in 45% of admissions, followed by an intervention in 81% of them. Patients who received an intervention had lower creatinine clearance levels and more regular medications including antibacterials for systemic use, diuretics, and psychoanaleptics. The two resulting interpretable models comprised either 6 or 17 predictors of a pharmaceutical intervention.</p><p><strong>Conclusions: </strong>Pharmacy software data may be used for more efficient prioritization of patients using specific criteria. Rule-based models are promising avenues to help clinical pharmacists systematically identify patients requiring pharmaceutical intervention, but further work is warranted.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Health and medication beliefs among South Koreans as a culturally and linguistically diverse population in Australia.","authors":"Ebuka-Olisaemeka Nwafor, Julie Stevens, Sarah Hosking, Eman Rafhi, Joon Soo Park, Sang-Woon Jeon, Kate Wang","doi":"10.1093/ijpp/riaf042","DOIUrl":"https://doi.org/10.1093/ijpp/riaf042","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adverse drug reaction enquiries to a hospital drug information service: impact of specialty-based clinical pharmacy practice.","authors":"Jeanie Misko, Matthew Rawlins","doi":"10.1093/ijpp/riaf040","DOIUrl":"https://doi.org/10.1093/ijpp/riaf040","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of quality indicators for a community pharmacy setting.","authors":"Ann Helen Jakobsen, Noriko Sato, Timothy F Chen, Kenji Fujita, Lars Småbrekke, Kjell H Halvorsen","doi":"10.1093/ijpp/riaf030","DOIUrl":"https://doi.org/10.1093/ijpp/riaf030","url":null,"abstract":"<p><strong>Objectives: </strong>Community pharmacies in Norway offer accessible healthcare services that require monitoring. Relevant and realistic quality indicators (QIs) must be developed to establish standards. This study aimed to establish consensus on healthcare quality measures in a community pharmacy setting by implementing two distinct approaches.</p><p><strong>Methods: </strong>A comprehensive multi-phase research design was implemented to identify, define, and select potential QIs for community pharmacies. Potential QIs were identified and nominated from workshops, focus groups, and literature. Thirteen panellists were recruited for a modified Delphi study over two rounds. We used the RAND/UCLA Appropriateness Method (RAM) panel median ratings and disagreement index (DI) to assess appropriateness and disagreement and define consensus.</p><p><strong>Key findings: </strong>We identified 192 QIs from workshops, focus groups and literature searches. After duplicates were removed and QIs with similar wording were merged, 137 QIs were nominated for the first Delphi round. The panellists deemed 61 appropriate, two inappropriate and excluded six QIs in the first round. The remaining 68 QIs were assessed in Round 2, where 23 achieved consensus as appropriate without disagreement. After DI was calculated, the number of QIs categorized as appropriate without disagreement after Round 1 and 2 was 34 and 10, respectively.</p><p><strong>Conclusion: </strong>This study demonstrates the use of the RAM combined with the DI to establish consensus on healthcare quality measures, i.e. QIs for community pharmacy services. Our findings indicate that the number of QIs considered acceptable is strongly impacted by the method chosen to handle disagreement in the ratings. Incorporating DI and conventional RAM disagreement calculations reduced the number of QIs deemed acceptable by half.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A systematic review of pharmaceutical care interventions in patients with rheumatoid arthritis.","authors":"Alana Teles Costa, Hygor Rafael da Silva Lima, Divaldo Pereira de Lyra Júnior, Alfredo de Oliveira Filho, Cristiani Isabel Banderó Walker","doi":"10.1093/ijpp/riaf029","DOIUrl":"https://doi.org/10.1093/ijpp/riaf029","url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review aimed to describe the work process of pharmaceutical care provided to patients with rheumatoid arthritis (RA).</p><p><strong>Methods: </strong>A systematic review was undertaken based on a search of six databases. The protocol was registered in PROSPERO (CRD42020133705). The inclusion criteria were randomized clinical trials (RCTs) with pharmaceutical care as an intervention in patients previously diagnosed with RA. Two investigators independently selected the studies, extracted data, and assessed their methodological quality. The RoB 2 tool was used to evaluate the quality of the studies. A narrative synthesis of results was provided.</p><p><strong>Key findings: </strong>A total of 3078 titles were found in the initial search, but only six RCTs, with a total of 337 patients, met the established inclusion criteria. These RCTs had some limitations, and only one had a low risk of bias. In most studies (66.6%), the service performed as an intervention had low complexity, was focused only on health education and did not have an individualized care plan for each patient. Telephone interviews or counseling sessions prevailed. The most evaluated outcome was medication adherence. When the intervention was remote and of shorter duration, the improvement in medication adherence was up to 8% (P < .05), whereas when a pharmacotherapeutic follow-up service was provided, this improvement reached 59% (P = .002). Pharmaceutical intervention was also associated with a significant improvement in beliefs about medications, patient satisfaction, reduced drug-related problems, and the cost of treatment.</p><p><strong>Conclusion: </strong>The pharmaceutical care processes should be adjusted to consider the complexity of treatment and patient profiles to produce tailored care plans.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are pharmacists adequately prepared to navigate ethical dilemmas in vaccinating children and adolescents?","authors":"Ashenafi Kibret Sendekie, Petra Czarniak, Leanne Chalmers, Tin Fei Sim","doi":"10.1093/ijpp/riaf035","DOIUrl":"https://doi.org/10.1093/ijpp/riaf035","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144110453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Public perceptions of community pharmacy roles in public health services: further content validity analysis of free text comments from the PubPharmQ Questionnaire.","authors":"Sarah L Brown, Jordan E Smith, Rose Rapado, Amie-Louise Prior, Delyth H James","doi":"10.1093/ijpp/riaf031","DOIUrl":"https://doi.org/10.1093/ijpp/riaf031","url":null,"abstract":"<p><strong>Objectives: </strong>Establishing the extent to which the public is ready to engage in community pharmacy (CP)-based public-health-related services in the UK is essential for maximizing uptake. The PubPharmQ was developed to measure public perceptions of these roles to identify the barriers to and facilitators for service uptake. The aim of this paper is to describe further content validity testing of the PubPharmQ, through analysis of the qualitative free-text comments provided by participants during the psychometric testing phase of questionnaire development.</p><p><strong>Methods: </strong>Template analysis was undertaken of free-text comments provided by participants during the development and psychometric testing of the PubPharmQ, allowing for deductive and inductive analysis across the dataset.</p><p><strong>Key findings: </strong>Of the 306 respondents who completed the PubPharmQ, 78 (25.5%) provided at least one free-text comment (total 172 comments). Six themes were constructed from the data. Four themes, Role in Public Health, Relationship, Privacy, and Expertise, were deductively mapped from PubPharmQ scales. Two new themes were identified inductively; Perceived Capacity (i.e. perceived staff capacity to deliver public health roles) and Care-seeking Behaviour: Pharmacy First (i.e. likelihood to access CP for advice before another healthcare provider).</p><p><strong>Conclusions: </strong>These findings provide further underpinning support for the PubPharmQ content validity whilst highlighting one further potential perceived barrier to the public's engagement with public-health-related-services in the CP (i.e. Capacity). Future use of the PubPharmQ should consider adding questions relating to perceived capacity of CP staff to deliver public-health-related services, and the likelihood of seeking advice from CP first.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144110590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ending nuclear weapons, before they end us†.","authors":"Kamran Abbasi, Parveen Ali, Virginia Barbour, Marion Birch, Inga Blum, Peter Doherty, Andy Haines, Ira Helfand, Richard Horton, Kati Juva, Jose F Lapena, Robert Mash, Olga Mironova, Arun Mitra, Carlos Monteiro, Elena N Naumova, David Onazi, Tilman Ruff, Peush Sahni, James Tumwine, Carlos Umaña, Paul Yonga, Chris Zielinski","doi":"10.1093/ijpp/riaf032","DOIUrl":"https://doi.org/10.1093/ijpp/riaf032","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Variation in the potentially inappropriate use of antipsychotic and benzodiazepine medications among individuals receiving residential medication management reviews.","authors":"Mouna J Sawan, Alexander J Clough, Jodie Hillen, Andrew R Zullo, Daniela C Moga, Natalie Soulsby, Danijela Gnjidic","doi":"10.1093/ijpp/riaf028","DOIUrl":"https://doi.org/10.1093/ijpp/riaf028","url":null,"abstract":"<p><strong>Objectives: </strong>To describe the variation in the use of potentially inappropriate antipsychotic and benzodiazepine medications in residents who have received a medication review and to evaluate the extent to which this variation is associated with aged care home (ACH) and resident characteristics.</p><p><strong>Methods: </strong>This cross-sectional, retrospective study used pharmacist-extracted data from 15,442 residents across 342 Australian ACHs who had a medication review during 2019. The proportion of residents receiving ≥1 potentially inappropriate antipsychotic and benzodiazepine medication according to Beers criteria were classified into quintiles by facility usage (Q1-Q5). Quintile characteristics were compared using descriptive analysis of facility and resident data. Logistic regression was used to compare individual usage between residents in each quintile adjusting for facility and resident characteristics.</p><p><strong>Key findings: </strong>The cohort had mean age 85 years (SD ±9), with less than 14% of residents in Q1 (n = 68), and >31% of residents in Q5 (n = 68) using an antipsychotic. For benzodiazepines, these proportions were <19% in Q1 (n = 68) and >45% in Q5 (n = 67). Facilities in major cities were significantly more likely to report antipsychotic (Q1:74% vs Q5:88%, P = .03) and benzodiazepine use (Q1:69% vs Q5:87%, P = .015). Residents in Q5 were seven times more likely to be prescribed an antipsychotic (aOR:7.22, 95% CI:5.93-8.79) than residents in Q1, and eight times more likely to be prescribed a benzodiazepine (aOR:8.57, 95% CI 7.33-10.01, P < .001) than residents in Q1.</p><p><strong>Conclusions: </strong>Significant variation exists in potentially inappropriate antipsychotic and benzodiazepine use among ACH residents receiving a medication review highlighting the need for further research to reduce prescribing of these high-risk medications.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144019688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}